Stephen G Schwartz

Summary

Affiliation: University of Miami
Country: USA

Publications

  1. doi request reprint Ruboxistaurin mesilate hydrate for diabetic retinopathy
    Stephen G Schwartz
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Naples, FL, USA
    Drugs Today (Barc) 45:269-74. 2009
  2. ncbi request reprint Fluocinolone acetonide implantable device for diabetic retinopathy
    Stephen G Schwartz
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, FL, USA
    Curr Pharm Biotechnol 12:347-51. 2011
  3. ncbi request reprint Hot Topics in Pharmacogenetics of Age-Related Macular Degeneration
    Stephen G Schwartz
    Bascom Palmer Eye Institute at Naples, 3880 Tamiami Trail North, Naples, FL 34103, USA
    Curr Pharm Des . 2016
  4. pmc Update on the prevention and treatment of endophthalmitis
    Stephen G Schwartz
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 311 9 Street North, 100, Naples, FL 34102 239 659 3937 FAX 239 659 3982
    Expert Rev Ophthalmol 9:425-430. 2014
  5. pmc Endophthalmitis Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections
    Stephen G Schwartz
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 311 9th Street North, 100, Naples, FL 34102, USA
    Curr Ophthalmol Rep 2:1-5. 2014
  6. ncbi request reprint Controversies in Topical Antibiotics Use with Intravitreal Injections
    Stephen G Schwartz
    Bascom Palmer Eye Institute, 3880 Tamiami Trail North, Naples, FL, 34103
    Curr Pharm Des 21:4703-6. 2015
  7. ncbi request reprint Update on Pharmacologic Retinal Vascular Toxicity
    Stephen G Schwartz
    Bascom Palmer Eye Institute, 3880 Tamiami Trail North, Naples, FL, 34103, USA
    Curr Pharm Des 21:4694-7. 2015
  8. pmc Uses of the word "macula" in written English, 1400-present
    Stephen G Schwartz
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Naples, FL Electronic address
    Surv Ophthalmol 59:649-54. 2014
  9. pmc Pharmacogenetics and age-related macular degeneration
    Stephen G Schwartz
    Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, 311 9th Street North, No 100, Naples, FL 34102, USA
    J Ophthalmol 2011:252549. 2011
  10. pmc Methicillin-resistant Staphylococcus epidermidis isolation from the vitrectomy specimen four hours after initial treatment with vancomycin and ceftazidime
    Golnaz Javey
    Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, TX, USA
    Clin Ophthalmol 4:101-4. 2010

Collaborators

Detail Information

Publications62

  1. doi request reprint Ruboxistaurin mesilate hydrate for diabetic retinopathy
    Stephen G Schwartz
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Naples, FL, USA
    Drugs Today (Barc) 45:269-74. 2009
    ..The U.S. Food and Drug Administration issued an approvable letter for ruboxistaurin in 2006, but at this time the medication is not available for routine clinical use...
  2. ncbi request reprint Fluocinolone acetonide implantable device for diabetic retinopathy
    Stephen G Schwartz
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, FL, USA
    Curr Pharm Biotechnol 12:347-51. 2011
    ..Combination photocoagulation and pharmacotherapy with these devices has not yet been reported...
  3. ncbi request reprint Hot Topics in Pharmacogenetics of Age-Related Macular Degeneration
    Stephen G Schwartz
    Bascom Palmer Eye Institute at Naples, 3880 Tamiami Trail North, Naples, FL 34103, USA
    Curr Pharm Des . 2016
    ..However, at this time there are no validated associations. With respect to AMD, pharmacogenetics remains an intriguing area of research but is not helpful for routine clinical management...
  4. pmc Update on the prevention and treatment of endophthalmitis
    Stephen G Schwartz
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 311 9 Street North, 100, Naples, FL 34102 239 659 3937 FAX 239 659 3982
    Expert Rev Ophthalmol 9:425-430. 2014
    ..Future trends may involve increasing utilization of polymerase chain reaction for diagnosis, and possibly office-based pars plana vitrectomy for treatment of endophthalmitis...
  5. pmc Endophthalmitis Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Injections
    Stephen G Schwartz
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 311 9th Street North, 100, Naples, FL 34102, USA
    Curr Ophthalmol Rep 2:1-5. 2014
    ..Despite these precautions, some patients will develop endophthalmitis following intravitreal anti-VEGF injections, and outcomes may be poor despite prompt and appropriate therapy...
  6. ncbi request reprint Controversies in Topical Antibiotics Use with Intravitreal Injections
    Stephen G Schwartz
    Bascom Palmer Eye Institute, 3880 Tamiami Trail North, Naples, FL, 34103
    Curr Pharm Des 21:4703-6. 2015
    ..At this time, antiseptics (specifically povidone-iodine), rather than antibiotics, are preferred for the majority of patients undergoing intravitreal injections. ..
  7. ncbi request reprint Update on Pharmacologic Retinal Vascular Toxicity
    Stephen G Schwartz
    Bascom Palmer Eye Institute, 3880 Tamiami Trail North, Naples, FL, 34103, USA
    Curr Pharm Des 21:4694-7. 2015
    ..Toxicity may be asymptomatic or may cause irreversible visual loss. By maintaining a high index of suspicion, the correct diagnosis can usually be made. ..
  8. pmc Uses of the word "macula" in written English, 1400-present
    Stephen G Schwartz
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Naples, FL Electronic address
    Surv Ophthalmol 59:649-54. 2014
    ..Macula" has been used in multiple contexts in written English. Modern databases provide powerful tools to explore historical uses of this word, which may be underappreciated by contemporary ophthalmologists...
  9. pmc Pharmacogenetics and age-related macular degeneration
    Stephen G Schwartz
    Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, 311 9th Street North, No 100, Naples, FL 34102, USA
    J Ophthalmol 2011:252549. 2011
    ..At this time, the data are not consistent and no definite conclusions may be drawn. As clinical trials data continue to accumulate, these relationships may become more apparent...
  10. pmc Methicillin-resistant Staphylococcus epidermidis isolation from the vitrectomy specimen four hours after initial treatment with vancomycin and ceftazidime
    Golnaz Javey
    Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, TX, USA
    Clin Ophthalmol 4:101-4. 2010
    ..This case illustrates the time lag necessary to sterilize the vitreous cavity, and suggests a possible two-step staged treatment strategy for situations in which access to PPV equipment and support staff may be limited...
  11. doi request reprint "Floater scotoma" demonstrated on spectral-domain optical coherence tomography and caused by vitreous opacification
    Stephen G Schwartz
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida 34102, USA
    Ophthalmic Surg Lasers Imaging Retina 44:415-8. 2013
    ..This finding may be useful in objectively documenting the status of vitreous opacification and verifying the patient's complaint of symptomatic floaters, a so-called "floater scotoma"...
  12. doi request reprint Congenital hypertrophy of the retinal pigment epithelium: choroidal cavitation demonstrated on spectral-domain OCT
    Stephen G Schwartz
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida 34102, USA
    Ophthalmic Surg Lasers Imaging Retina 44:301-2. 2013
    ..Although photoreceptor atrophy overlying congenital hypertrophy of the retinal pigment epithelium has been described on time-domain OCT, this patient manifested a previously unrecognized tomographic feature...
  13. ncbi request reprint Genetics and diabetic retinopathy
    Stephen G Schwartz
    Bascom Palmer Eye Institute at Naples, 311 9th Street North 100, Naples, FL 34102, USA
    Curr Diabetes Rev 9:86-92. 2013
    ..This may be due to small sample sizes, differences in study design, underlying genetic differences between study populations, or other factors. As we continue to collect data, these relationships may become more clear...
  14. pmc The ARMS2 A69S variant and bilateral advanced age-related macular degeneration
    Stephen G Schwartz
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA
    Retina 32:1486-91. 2012
    ....
  15. ncbi request reprint Pharmacotherapy for diabetic retinopathy
    Stephen G Schwartz
    University of Miami Miller School of Medicine, Bascom Palmer Eye Institute, 311 9th Street North, 100, Naples, FL 34102, USA
    Expert Opin Pharmacother 10:1123-31. 2009
    ..Although no agent is now approved by the FDA for this purpose, many agents are now being studied in randomized clinical trials (RCTs)...
  16. pmc Pharmacotherapies for diabetic retinopathy: present and future
    Stephen G Schwartz
    Bascom Palmer Eye Institute, Retina Center at Naples, 311 9th Street North, Naples, FL 34102, USA
    Exp Diabetes Res 2007:52487. 2007
    ..Other medications under investigation include the fluocinolone acetonide implantable device, extended-release dexamethasone implant, oral ruboxistaurin, and intravitreal hyaluronidase...
  17. ncbi request reprint Beta1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers
    Stephen G Schwartz
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida 34102, USA
    Ophthalmology 112:2131-6. 2005
    ..To evaluate the relationship between polymorphisms in the gene encoding the beta1-adrenergic receptor (beta1-AR) and clinical response to betaxolol hydrochloride 0.25% in a small pilot study of normal volunteers...
  18. doi request reprint Endophthalmitis after intravitreal injections
    Stephen G Schwartz
    University of Miami Miller School of Medicine, Bascom Palmer Eye Institute at Naples, Naples, FL 34102, USA
    Expert Opin Pharmacother 10:2119-26. 2009
    ..Infectious endophthalmitis must be differentiated from noninfectious inflammation. Depending on the series, the risk of endophthalmitis is very low. The use of a standardized injection protocol can reduce the risk of infection...
  19. doi request reprint Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion
    Ninel Z Gregori
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 900 NW 17th St, Miami, FL 33136, USA
    Retina 28:1325-37. 2008
    ..To evaluate the long-term safety and efficacy of intravitreal bevacizumab injections (Avastin, Genentech Inc., San Francisco, CA) for the treatment of macular edema secondary to central retinal vein occlusions...
  20. doi request reprint Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center
    Andrew A Moshfeghi
    Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida 33418, USA
    Retina 31:662-8. 2011
    ....
  21. pmc Rates of Reoperation and Retinal Detachment after Macular Hole Surgery
    Kamyar Vaziri
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida
    Ophthalmology 123:26-31. 2016
    ..To evaluate rates of reoperation and retinal detachment (RD) after macular hole surgery...
  22. pmc Variants at chromosome 10q26 locus and the expression of HTRA1 in the retina
    Gaofeng Wang
    John P Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Exp Eye Res 112:102-5. 2013
    ..These results suggest that the AMD-associated variants in the chromosome 10q26 locus do not significantly affect the expression of HTRA1. ..
  23. ncbi request reprint Thirty-two month follow-up of successful treatment of choroidal neovascularization from angioid streaks with intravitreal bevacizumab
    Jaclyn L Kovach
    Bascom Palmer Eye Institute, Retina Center at Naples, 311 9th Street North, 100, Naples, FL 34102, USA
    Ophthalmic Surg Lasers Imaging 40:77-9. 2009
    ..In certain patients with choroidal neovascularization from angioid streaks, intravitreal bevacizumab may produce normalization of visual acuity and macular anatomy for an extended period of time...
  24. doi request reprint Glucocorticoid receptor polymorphisms and intraocular pressure response to intravitreal triamcinolone acetonide
    Sabrina M Gerzenstein
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA
    Ophthalmic Genet 29:166-70. 2008
    ..The etiology of the steroid response is poorly understood, although a genetic determinant has long been suspected. We performed a pharmacogenomic association study with glucocorticoid receptor polymorphisms...
  25. pmc Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms
    Digna R Velez Edwards
    Dr John T Macdonald Foundation Department of Human Genetics and John P Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, Florida, USA
    Invest Ophthalmol Vis Sci 51:1873-9. 2010
    ..These results highlight the genetic and environmental complexity of the etiologic architecture of AMD; however, further replication is necessary to validate them...
  26. doi request reprint Safety and efficacy of intravitreal bevacizumab (avastin) for the management of branch and hemiretinal vein occlusion
    Ninel Z Gregori
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida 33136, USA
    Retina 29:913-25. 2009
    ..To evaluate the safety and efficacy of intravitreal bevacizumab (Avastin, Genentech) for the treatment of macular edema (ME) secondary to branch retinal vein occlusion (BRVO) and hemiretinal vein occlusion (HRVO)...
  27. pmc Analysis of single nucleotide polymorphisms in the NOS2A gene and interaction with smoking in age-related macular degeneration
    Juan A Ayala-Haedo
    John P Hussman Institute for Human Genomics and the Dr John T Macdonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Ann Hum Genet 74:195-201. 2010
    ..Our data suggests that SNPs in the NOS2A gene are associated with increased risk for AMD and might modulate the effect of smoking on AMD...
  28. doi request reprint Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study
    David M Brown
    Vitreoretinal Consultants, Methodist Hospital, Houston, Texas 77030, USA
    Ophthalmology 116:57-65.e5. 2009
    ....
  29. doi request reprint Fovea-sparing retinal detachments: time to surgery and visual outcomes
    Charles C Wykoff
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 900 NW 17th Street, Miami, FL 33136, USA
    Am J Ophthalmol 150:205-210.e2. 2010
    ..To study the effect of the duration from initial evaluation to repair on outcomes for fovea-sparing rhegmatogenous retinal detachment (RRD)...
  30. pmc Whole exome sequencing of extreme age-related macular degeneration phenotypes
    Rebecca J Sardell
    John P Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL
    Mol Vis 22:1062-76. 2016
    ..We hypothesized that these phenotypically extreme individuals were more likely to carry rare risk or protective variants with large effect sizes...
  31. doi request reprint Initial outcomes following intravitreal ocriplasmin for treatment of symptomatic vitreomacular adhesion
    Brian T Kim
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA
    Ophthalmic Surg Lasers Imaging Retina 44:334-43. 2013
    ..The authors describe their initial clinical experience with ocriplasmin at a large academic center...
  32. pmc Analysis of the indel at the ARMS2 3'UTR in age-related macular degeneration
    Gaofeng Wang
    Dr John T Macdonald Foundation Department of Human Genetics, John P Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Hum Genet 127:595-602. 2010
    ..Conclusively, the indel at 3'UTR of ARMS2 actually contains two side-by-side indels. The indels are associated with risk of AMD, but not correlated with ARMS2 mRNA level...
  33. doi request reprint Drug delivery techniques for treating age-related macular degeneration
    Stephen G Schwartz
    University of Miami Miller School of Medicine, Bascom Palmer Eye Institute, 311 9th Street North, Naples, 34102, USA
    Expert Opin Drug Deliv 11:61-8. 2014
    ..In addition, the cumulative risks of endophthalmitis and other complications increase with the number of injections...
  34. ncbi request reprint Lack of toxicity of stainless steel retinal tacks during 21 years of follow-up
    Golnaz Javey
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA
    Ophthalmic Surg Lasers Imaging 40:75-6. 2009
    ..Although retinal tacks are no longer used, this case report suggests that intraocular stainless steel may cause minimal or no retinal toxicity during long-term follow-up...
  35. doi request reprint Update on retinal detachment surgery
    Stephen G Schwartz
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 900 NW 17 Street, Miami, FL 33136, USA
    Curr Opin Ophthalmol 24:255-61. 2013
    ..Update on controversies in the surgical management of rhegmatogenous retinal detachment...
  36. ncbi request reprint Twenty-year follow-up for scleral buckling
    Stephen G Schwartz
    McPherson Retina Center, Cullen Eye Institute, Baylor College of Medicine, Houston, TX 77030, USA
    Arch Ophthalmol 120:325-9. 2002
    ..To the report 20-year follow-up data for patients receiving a scleral buckle for treatment of a primary rhegmatogenous retinal detachment (RRD)...
  37. ncbi request reprint Primary retinal detachment: scleral buckle or pars plana vitrectomy?
    Stephen G Schwartz
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida 33136, USA
    Curr Opin Ophthalmol 17:245-50. 2006
    ..There remains no consensus among vitreoretinal surgeons regarding the optimal management of primary rhegmatogenous retinal detachment. In this article, fundamental principles are discussed and applied to recent clinical reports...
  38. ncbi request reprint Bilateral CRAO and CRVO from thrombotic thrombocytopenic purpura: OCT findings and treatment with triamcinolone acetonide and bevacizumab
    Stephen G Schwartz
    Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, Florida 34102, USA
    Ophthalmic Surg Lasers Imaging 37:420-2. 2006
    ..Treatment of both eyes with intravitreal bevacizumab (1.25 mg) and panretinal photocoagulation was effective in eliminating iris neovascularization, although the patient lost all visual function...
  39. pmc Progression Rate From Intermediate to Advanced Age-Related Macular Degeneration Is Correlated With the Number of Risk Alleles at the CFH Locus
    Rebecca J Sardell
    John P Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida, United States
    Invest Ophthalmol Vis Sci 57:6107-6115. 2016
    ..Progression rate of age-related macular degeneration (AMD) varies substantially, yet its association with genetic variation has not been widely examined...
  40. ncbi request reprint Retained lens fragments in resident-performed cataract extractions
    Stephen G Schwartz
    Department of Ophthalmology, Medical College, Virginia Campus of Virginia Commonwealth University, Richmond, USA
    CLAO J 28:44-7. 2002
    ..To investigate the incidence, management, and outcome of retained lens fragments following resident-performed cataract extraction...
  41. pmc Emerging pharmacotherapies for diabetic macular edema
    Golnaz Javey
    Department of Ophthalmology, Baylor College of Medicine, 7200 B Cambridge Street, Houston, TX 77030, USA
    Exp Diabetes Res 2012:548732. 2012
    ..Pharmacotherapies for DME include locally and systemically administered agents. We review several agents that have been studied for the treatment of DME...
  42. doi request reprint Comparison of intravitreal bevacizumab followed by ranibizumab for the treatment of neovascular age-related macular degeneration
    Kimberly E Stepien
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida 33136, USA
    Retina 29:1067-73. 2009
    ..To compare outcomes after switching from intravitreal bevacizumab (Avastin) to ranibizumab (Lucentis) in patients with neovascular age-related macular degeneration (AMD)...
  43. pmc Update on corticosteroids for diabetic macular edema
    Stephen G Schwartz
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL
    Clin Ophthalmol 10:1723-30. 2016
    ..There is no current consensus regarding the use of corticosteroids, but they are valuable for selected patients with center-involving DME. ..
  44. pmc Tamponade in the surgical management of retinal detachment
    Kamyar Vaziri
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA
    Clin Ophthalmol 10:471-6. 2016
    ..Different tamponade agents have unique benefits and risks, and choice of the agent should be individualized according to the characteristics of the patient and RD, as well as perioperative and postoperative factors. ..
  45. doi request reprint Extended duration strategies for the pharmacologic treatment of diabetic retinopathy: current status and future prospects
    Michael W Stewart
    A Department of Ophthalmology, Mayo Clinic Florida, Jacksonville, FL, USA
    Expert Opin Drug Deliv 13:1277-87. 2016
    ..A series of intraocular injections is usually required before disease modulation decreases the treatment burden in some patients, but others with chronic diabetic macular edema may require intensive longer-term therapy...
  46. ncbi request reprint Medications and retinal toxicity
    Stephen G Schwartz
    Department of Ophthalmology, Medical College of Virginia, Commonwealth University, 8th Floor, MCV Box 980262, 1101 E Marshall Street, Richmond, VA 23298 0262, USA
    Ophthalmol Clin North Am 15:517-28. 2002
    ..When assessing any patient for a retinal disturbance, it is imperative to question the patient regarding the use of systemic medications. This is especially important as more and more medications are brought to the market each year...
  47. pmc Anti-VEGF Treatment Strategies for Wet AMD
    Jaclyn L Kovach
    Department of Ophthalmology, Bascom Palmer Eye Institute, School of Medicine, University of Miami, 311 9th St North, Naples, FL 34102, USA
    J Ophthalmol 2012:786870. 2012
    ..During this time, treatment strategies have evolved from a monthly dosing schedule to individualized regimens. This paper will review the currently available anti-VEGF agents and evidence-based treatment strategies...
  48. pmc The Monocular Duke of Urbino
    Stephen G Schwartz
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA
    Ophthalmol Eye Dis 8:15-19. 2016
    ..Whether or not the Duke actually underwent the surgery cannot be proven, but it seems unlikely that this would have substantially improved his visual function...
  49. pmc Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy
    Stephen G Schwartz
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 311 9th Street North, 100, Naples, USA, FL 34102
    Cochrane Database Syst Rev . 2009
    ..Retinal detachment (RD) with proliferative vitreoretinopathy (PVR) often requires surgery. During surgery, a tamponade agent is needed to reduce the rate of recurrent retinal detachment...
  50. pmc Genetics and age-related macular degeneration: a practical review for the clinician
    Stephen G Schwartz
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA
    Clin Ophthalmol 10:1229-35. 2016
    ..However, at present, the bulk of the available peer-reviewed evidence suggests that genetic testing is more useful as a research tool than for clinical management of patients. ..
  51. pmc Antibiotic prophylaxis: different practice patterns within and outside the United States
    Stephen G Schwartz
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA
    Clin Ophthalmol 10:251-6. 2016
    ..At this time, there is no global consensus and it appears unlikely that additional major clinical trials will conclusively define the optimal endophthalmitis prophylaxis techniques. ..
  52. doi request reprint Current advances in the treatment of neovascular age-related macular degeneration
    Victor M Villegas
    A Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA
    Expert Opin Drug Deliv 14:273-282. 2017
    ..The results of ongoing randomized clinical trials will answer the important concerns surrounding new drugs and delivery devices: safety and visual outcomes...
  53. doi request reprint Emerging drugs for diabetic macular edema
    Stephen G Schwartz
    University of Miami Miller School of Medicine, Bascom Palmer Eye Institute, 311 9th Street North, 100, Naples, FL 34102, USA
    Expert Opin Emerg Drugs 19:397-405. 2014
    ..Traditionally, photocoagulation was standard treatment, but pharmacologic therapies are becoming increasingly used for this purpose. All currently available drug therapies for DME are either anti-VEGF agents or corticosteroids...
  54. pmc Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy
    Stephen G Schwartz
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, USA
    Cochrane Database Syst Rev 2:CD006126. 2014
    ..Either way, a tamponade agent (gas or silicone oil) is needed during surgery to reduce the rate of postoperative recurrent RD...
  55. ncbi request reprint Choroideremia with polydactyly mimicking the Laurence-Moon-Bardet-Biedl syndrome
    Stephen G Schwartz
    Department of Ophthalmology, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, Virginia 23298 0262, USA
    Retina 23:413-5. 2003
  56. pmc A medieval fallacy: the crystalline lens in the center of the eye
    Christopher T Leffler
    Department of Ophthalmology, Virginia Commonwealth University, Richmond, VA, USA
    Clin Ophthalmol 10:649-62. 2016
    ..To determine whether, as most modern historians have written, ancient Greco-Roman authors believed the crystalline lens is positioned in the center of the eye...
  57. pmc Progression of Transsynaptic Retinal Degeneration With Spectral-Domain Optical Coherence Tomography
    Stephen G Schwartz
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL
    Am J Ophthalmol Case Rep 5:67-72. 2017
    ..To illustrate the progression of retrograde transsynaptic retinal degeneration using spectral- domain optical coherence tomography (SD-OCT)...
  58. doi request reprint New Therapeutic Approaches in Diabetic Retinopathy
    Kamyar Vaziri
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 900 NW 17th Street, Miami, FL 33136, USA
    Rev Diabet Stud 12:196-210. 2015
    ..This review provides an update on the novel developments in the treatment of diabetic retinopathy. ..
  59. ncbi request reprint Intravitreal hemoglobin spherulosis: a rare complication of subretinal hemorrhage
    Stephen G Schwartz
    Cullen Eye Institute, Baylor College of Medicine, 6565 Fannin St, NC 205, Houston, TX 77030, USA
    Arch Ophthalmol 120:85-7. 2002
  60. pmc Risk factors for endophthalmitis and retinal detachment with retained intraocular foreign bodies
    D Wilkin Parke
    Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, FL 33136, USA
    J Ophthalmol 2012:758526. 2012
    ..Risk factors for RD were posterior entry site, posterior segment IOFB, endophthalmitis, and retinal impact sites. No eyes developed endophthalmitis after presentation...
  61. pmc Pars plana vitrectomy for primary rhegmatogenous retinal detachment
    Stephen G Schwartz
    Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA
    Clin Ophthalmol 2:57-63. 2008
    ..At this time, the choice of SB versus PPV should be based on the characteristics of the RD, the patient as a whole, and the experience and preference of the individual retinal surgeon...
  62. doi request reprint Ocular complication of intense pulsed light therapy: iris photoablation
    Golnaz Javey
    Department of Ophthalmology, Baylor College of Medicine, Houston, Texas Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, Florida
    Dermatol Surg 36:1466-8. 2010
    ..The authors have indicated no significant interest with commercial supporters...